ATRC - AtriCure, Inc.

34.65
0.980   2.828%

Share volume: 1,115,961
Last Updated: 04-29-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 0.00%

PREVIOUS CLOSE
CHG
CHG%
$33.67
0.98
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
19%
Profitability 0%
Dept financing 11%
Liquidity 56%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
3.74%
1 Month
7.41%
3 Months
-14.66%
6 Months
-0.52%
1 Year
43.66%
2 Year
-23.20%
Key data
Stock price
$34.65
P/E Ratio 
0.00
DAY RANGE
$33.47 - $35.60
EPS 
-$0.95
52 WEEK RANGE
$18.94 - $43.11
52 WEEK CHANGE
$39.94
MARKET CAP 
1.490 B
YIELD 
N/A
SHARES OUTSTANDING 
48.698 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
1.67
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$638,376
AVERAGE 30 VOLUME 
$524,229
Company detail
CEO: Michael H. Carrel
Region: US
Website: atricure.com
Employees: 1,050
IPO year: 2005
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue and systems, and intercostal nerves. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products. CryoICE Cryoablation System enables the user to make linear ablations of varied lengths. EPi-Sense Guided Coagulation System is used to treat persistent atrial fibrillation.

Recent news
loading